OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Effect of Melatonin on Thrombosis, Sepsis and Mortality Rate in COVID-19 Patients
Zainab Thanon Hasan, Mohammed Qasim Alatrakji, Ahmed Kayes Mehuaiden
International Journal of Infectious Diseases (2021) Vol. 114, pp. 79-84
Open Access | Times Cited: 84

Showing 1-25 of 84 citing articles:

Melatonin attenuates sepsis-induced acute kidney injury by promoting mitophagy through SIRT3-mediated TFAM deacetylation
Zhiya Deng, Man He, Hongbin Hu, et al.
Autophagy (2023) Vol. 20, Iss. 1, pp. 151-165
Open Access | Times Cited: 53

Melatonin and Related Compounds: Antioxidant and Anti-Inflammatory Actions
Maria Anna Bantounou, Josip Plascevic, Helen F. Galley
Antioxidants (2022) Vol. 11, Iss. 3, pp. 532-532
Open Access | Times Cited: 40

Antineoplastic indole-containing compounds with potential VEGFR inhibitory properties
Dalia R. Aboshouk, Mohamed A. Youssef, Mohamed S. Bekheit, et al.
RSC Advances (2024) Vol. 14, Iss. 9, pp. 5690-5728
Open Access | Times Cited: 8

Melatonin: highlighting its use as a potential treatment for SARS-CoV-2 infection
Rüssel J. Reiter, Ramaswamy Sharma, Fedor Šimko, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 3
Open Access | Times Cited: 35

Are Nutraceuticals Effective in COVID-19 and Post-COVID Prevention and Treatment?
Alessia Catalano, Domenico Iacopetta, Jessica Ceramella, et al.
Foods (2022) Vol. 11, Iss. 18, pp. 2884-2884
Open Access | Times Cited: 34

Melatonin–Microbiome Two-Sided Interaction in Dysbiosis-Associated Conditions
Mara Ioana Ieșanu, Carmen Denise Mihaela Zahiu, Ioana-Alexandra Dogaru, et al.
Antioxidants (2022) Vol. 11, Iss. 11, pp. 2244-2244
Open Access | Times Cited: 31

Mechanisms and clinical evidence to support melatonin's use in severe COVID-19 patients to lower mortality
Dun‐Xian Tan, Rüssel J. Reiter
Life Sciences (2022) Vol. 294, pp. 120368-120368
Open Access | Times Cited: 29

An Overview of Drug Delivery Nanosystems for Sepsis-Related Liver Injury Treatment
Yi Lu, Yi Shi, Qian Wu, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 765-779
Open Access | Times Cited: 17

Role of Melatonin in Viral, Bacterial and Parasitic Infections
Georges J. M. Maestroni
Biomolecules (2024) Vol. 14, Iss. 3, pp. 356-356
Open Access | Times Cited: 5

Melatonin from Plants: Going Beyond Traditional Central Nervous System Targeting—A Comprehensive Review of Its Unusual Health Benefits
Lucas Fornari Laurindo, Otávio Augusto Garcia Simili, Adriano Cressoni Araújo, et al.
Biology (2025) Vol. 14, Iss. 2, pp. 143-143
Open Access

Melatonin Exerts Positive Effects on Sepsis Through Various Beneficial Mechanisms
Jing Xu, Cui Liang, You Shang, et al.
Drug Design Development and Therapy (2025) Vol. Volume 19, pp. 1333-1345
Open Access

Melatonin drugs inhibit SARS-CoV-2 entry into the brain and virus-induced damage of cerebral small vessels
Erika Cecon, Daniela Fernandois, Nicolas Renault, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 7
Open Access | Times Cited: 23

Redox Homeostasis Alteration Is Restored through Melatonin Treatment in COVID-19 Patients: A Preliminary Study
Marí­a Elena Soto, Israel Pérez-Torres, Linaloe Manzano-Pech, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4543-4543
Open Access | Times Cited: 4

Efficacy and safety of oral melatonin in patients with severe COVID-19: a randomized controlled trial
Ali Ameri, Masoomeh Asadi, Ava Ziaei, et al.
Inflammopharmacology (2022) Vol. 31, Iss. 1, pp. 265-274
Open Access | Times Cited: 20

Indole-Based Compounds as Potential Drug Candidates for SARS-CoV-2
Adel S. Girgis, Siva S. Panda, Benson M. Kariuki, et al.
Molecules (2023) Vol. 28, Iss. 18, pp. 6603-6603
Open Access | Times Cited: 10

Detection and complete genome sequence analysis of human adenovirus in children with acute diarrhea in Yunnan, China, 2015–2021
Yihui Cao, Jinghui Yang, Nan Li, et al.
Archives of Virology (2024) Vol. 169, Iss. 2
Open Access | Times Cited: 3

Unbalanced IDO1/IDO2 Endothelial Expression and Skewed Keynurenine Pathway in the Pathogenesis of COVID-19 and Post-COVID-19 Pneumonia
Marco Chilosi, Claudio Doglioni, Claudia Ravaglia, et al.
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1332-1332
Open Access | Times Cited: 17

The role of melatonin as an adjuvant in the treatment of COVID-19: A systematic review
Arezoo Faridzadeh, Arefeh Tabashiri, Hamid Heidarian Miri, et al.
Heliyon (2022) Vol. 8, Iss. 10, pp. e10906-e10906
Open Access | Times Cited: 16

Endoplasmic Reticulum Stress in Elderly Patients with COVID-19: Potential of Melatonin Treatment
Giou‐Teng Yiang, Chia‐Chao Wu, Chien‐Lin Lu, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 156-156
Open Access | Times Cited: 9

The relationship between anesthesia and melatonin: a review
Rui Guo, Junming Ye, Baozhen Liao, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 9

LIGHT POLLUTION: a systematic review about the impacts of artificial light on human health
Marli do Carmo Cupertino, Bianca Thiengo Guimarães, José Flávio Giardini Pimenta, et al.
Biological Rhythm Research (2022) Vol. 54, Iss. 3, pp. 263-275
Closed Access | Times Cited: 15

Immune Signature of COVID-19: In-Depth Reasons and Consequences of the Cytokine Storm
Paulina Niedźwiedzka-Rystwej, Adam Majchrzak, Sara Kurkowska, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4545-4545
Open Access | Times Cited: 13

Page 1 - Next Page

Scroll to top